S S Coburn1,2, L J Luecken3, I A Rystad3, B Lin3,4, K A Crnic3, N A Gonzales3. 1. Department of Psychology, Arizona State University, Tempe, AZ, USA. scoburn@childrensnational.org. 2. Division of Gastroenterology, Hepatology, and Nutrition, Children's National Medical Center, 111 Michigan Ave NW, Washington, DC, USA. scoburn@childrensnational.org. 3. Department of Psychology, Arizona State University, Tempe, AZ, USA. 4. Department of Psychology, University of Utah, Salt Lake City, UT, USA.
Abstract
INTRODUCTION: Recent research suggests that health disparities among low-SES and ethnic minority populations may originate from prenatal and early life exposures. Postpartum maternal depressive symptoms have been linked to poorer infant physical health, yet prenatal depressive symptoms not been thoroughly examined in relation to infant health. METHODS: In a prospective study of low-income Mexican American mothers and their infants, women (N = 322, median age 27.23, IQR = 22.01-32.54) completed surveys during pregnancy (median gestation 39.50, IQR = 38.71-40.14 weeks) and 12 weeks after birth. We investigated (1) if prenatal depressive symptoms predicted infant physical health concerns at 12 weeks of age, (2) whether these associations occurred above and beyond concurrent depressive symptoms, and (3) if birth weight, gestational age, and breastfeeding were mediators of prenatal depression predicting subsequent infant health. RESULTS: Higher prenatal depressive symptoms were associated with more infant physical health concerns at 12 weeks (p < .001), after accounting for 12-week maternal depressive symptoms, breastfeeding, gestational age, and birth weight. Twelve-week maternal depressive symptoms were concurrently associated with more infant health concerns (p < .01). Birth weight, gestational age, and breastfeeding were not associated with maternal depression or infant health concerns. DISCUSSION: Results establish a link between prenatal depressive symptoms and an elevated risk of poor health evident shortly after birth. These findings underscore the importance of the prenatal period as a possible sensitive period for infants' health, and the need for effective interventions for depression during pregnancy to mitigate potentially teratogenic effects on the developing fetus and reduce risks for later health concerns.
INTRODUCTION: Recent research suggests that health disparities among low-SES and ethnic minority populations may originate from prenatal and early life exposures. Postpartum maternal depressive symptoms have been linked to poorer infant physical health, yet prenatal depressive symptoms not been thoroughly examined in relation to infant health. METHODS: In a prospective study of low-income Mexican American mothers and their infants, women (N = 322, median age 27.23, IQR = 22.01-32.54) completed surveys during pregnancy (median gestation 39.50, IQR = 38.71-40.14 weeks) and 12 weeks after birth. We investigated (1) if prenatal depressive symptoms predicted infant physical health concerns at 12 weeks of age, (2) whether these associations occurred above and beyond concurrent depressive symptoms, and (3) if birth weight, gestational age, and breastfeeding were mediators of prenatal depression predicting subsequent infant health. RESULTS: Higher prenatal depressive symptoms were associated with more infant physical health concerns at 12 weeks (p < .001), after accounting for 12-week maternal depressive symptoms, breastfeeding, gestational age, and birth weight. Twelve-week maternal depressive symptoms were concurrently associated with more infant health concerns (p < .01). Birth weight, gestational age, and breastfeeding were not associated with maternal depression or infant health concerns. DISCUSSION: Results establish a link between prenatal depressive symptoms and an elevated risk of poor health evident shortly after birth. These findings underscore the importance of the prenatal period as a possible sensitive period for infants' health, and the need for effective interventions for depression during pregnancy to mitigate potentially teratogenic effects on the developing fetus and reduce risks for later health concerns.
Authors: T Mac Bird; Janet M Bronstein; Richard W Hall; Curtis L Lowery; Richard Nugent; Glen P Mays Journal: Pediatrics Date: 2010-07-05 Impact factor: 7.124
Authors: Elaine M Boyle; Gry Poulsen; David J Field; Jennifer J Kurinczuk; Dieter Wolke; Zarko Alfirevic; Maria A Quigley Journal: BMJ Date: 2012-03-01
Authors: Carson Kautz-Turnbull; Christie L M Petrenko; Elizabeth D Handley; Claire D Coles; Julie A Kable; Wladimir Wertelecki; Lyubov Yevtushok; Natalya Zymak-Zakutnya; Christina D Chambers Journal: Alcohol Clin Exp Res Date: 2021-05-17 Impact factor: 3.928
Authors: Dana M Lapato; Roxann Roberson-Nay; Robert M Kirkpatrick; Bradley T Webb; Timothy P York; Patricia A Kinser Journal: Clin Epigenetics Date: 2019-11-28 Impact factor: 6.551
Authors: Emily L Tuthill; Joshua D Miller; Shalean M Collins; Elizabeth M Widen; Maricianah Onono; Sera L Young Journal: Int Breastfeed J Date: 2020-01-16 Impact factor: 3.461